This report ocuses on the ormer linkage i

This report ocuses on the ormer linkage, i.e., the use o companiondiagnostic tests in personalized medicine. High-Growth Diagnostic Testing Markets There will be a steady increase in demand or new diagnostic testing ser ices inthe next i e-year period, along with pressures to impro e the quality o healthcare deli ered in the clinic and also to lower its costs. Clinical labsexperienced a substantial growth during the last decade. The emphasis in thisreport is on those companies that are acti ely de eloping and marketinghigh-growth diagnostic testing technologies in the clinical hospital market. Itde ines the dollar olume o sales, both worldwide and in the U.S., o themarket and analyzes the actors that in luence the size and growth o marketsegments.

The study goes on to discuss in detail trends that ha e de elopedwhich ha e stimulated this market, and also comments in detail patterns o in ormation processing in the high-growth diagnostic testing technologies.Moreo er, this exanimation pro ides an o er iew o the diagnostic testingmarket, including the latest in ormation regarding exciting new products andindustry trends. It will not only quanti y but also quali y the markethigh-growth segments as an area o research and in estment. orecasts o themarket and analyses o products in the worldwide prescriptions market willpro ide a basis or understanding the signi icance o past de elopments and uture possibilities within this therapeutic category. Key Diagnostic Testing Markets This report re iews the high-growth market segments or clinical laboratorytesting equipment and supplies in the clinical hospital market, using screeningreagents and instruments or analysis o indi idual components in blood, serumor plasma. urther, it examines the subsections o each market segment,including the clinical laboratory and research areas. Acti ity and trends in theclinical diagnostic market are discussed, including the numbers o institutionsusing this type o testing, and the actors that in luence purchasing acti ity.Discussion details the trends that ha e de eloped that stimulate this market,and o ers detailed comments on the patterns o in ormation processing inpoint-o -care (POC) testing instruments. The study sur eys most o the importantcompanies known to be marketing, manu acturing or de eloping instruments andreagents in the areas selected as high-growth diagnostic markets in the U.S andworldwide.

Each company is discussed in depth, with a section on its history,product line, business and marketing analysis, and a subjecti e commentary onthe company's position in its market and its strategic direction. Molecular Diagnostics Markets The technologies that constitute molecular diagnosticslike irst-generationampli ication, DNA probes, luorescent in situ hybridization ( ISH),second-generation biochips and micro luidics, next-generation signal detection,biosensors, and molecular labelsare in luencing the disco ery o therapeuticmolecules, the screening and diagnosis o patients, and the optimization o drugtherapy. In the past ew years, this rapidly e ol ing ield has seen se eral ascinating de elopments. This report describes the speci ic market segment o the in itro diagnostics market known as molecular diagnostics and includes allo the generally accepted clinical analytical acti ities in use today.